Combined antihypertensive in patients with high risk of cardiovascular events

Combined antihypertensive in patients with high risk of cardiovascular events

The article is devoted to the issue of optimizing blood pressure control in the patients with Type 2 diabetes mellitus, with or without arterial hypertension, by antihypertensive therapy with a fixed combination of low doses of perindopril and indapamide. Such therapeutic approach is consistent with...

Full description

Bibliographic Details
Main Author:	Yu. A. Karpov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2009-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	diabetes mellitus combined therapy prognosis
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1456

Similar Items

EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS
by: O. A. Koshel'skaya, et al.
Published: (2015-12-01)

Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus
by: M E Statsenko, et al.
Published: (2013-09-01)

Combined effects of antihypertensive medications: computer prognosis
by: O. A. Gomaskov, et al.
Published: (2008-10-01)

Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy
by: M E Statsenko, et al.
Published: (2014-08-01)

Algorithm for differential administration of combination antihypertensive therapy in patients with Type 2 diabetes mellitus
by: O. A. Koshelskaya, et al.
Published: (2013-08-01)

The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01)

The choice of combination antihypertensive therapy in patients with type 2 diabetes
by: O. A. Koshelskaya, et al.
Published: (2015-12-01)

Antihypertensive therapy and diabetes mellitus incidence: is it possible to reduce the risk?
by: M. G. Glezer
Published: (2008-12-01)

Impact of combination antihypertensive therapy on heart rate variability parameters and target organ status in patients with arterial hypertension and type 2 diabetes mellitus
by: M E Statsenko, et al.
Published: (2013-12-01)

TOLERABILITY OF VARIOUS ANTIHYPERTENSIVE COMBINATIONS
by: S. V. Malchikova, et al.
Published: (2016-01-01)

COMBINATION ANTIHYPERTENSION THERAPY: THE “UNDERRESEARCHED” COMBINATIONS
by: Yu. V. Kotovskaya, et al.
Published: (2017-06-01)

Cardiovascular risk, metabolic disturbances, and the choice of antihypertensive therapy
by: M. N. Mamedov, et al.
Published: (2011-08-01)

Combined antihypertensive medications
by: L. L. Kirichenko, et al.
Published: (2007-12-01)

State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes
by: M. E. Statsenko, et al.
Published: (2016-03-01)

State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes
by: M. E. Statsenko, et al.
Published: (2017-01-01)

Treatment of patients with high cardiovascular risk: a modern view on combined therapy
by: Z N Blankova, et al.
Published: (2017-03-01)

Treatment of patients with high cardiovascular risk: a modern view on combined therapy
by: Blankova Z.N., et al.
Published: (2017-02-01)

Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
by: Naim Shehadeh, et al.
Published: (2018-08-01)

METABOLIC EFFECTS OF VARIOUS ANTIHYPERTENSIVE DRUG COMBINATIONS
by: E. E. Alimova, et al.
Published: (2012-12-01)

CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION
by: T. A. Dronova, et al.
Published: (2014-07-01)

Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a cross-sectional preliminary study
by: Sepiso K. Masenga, et al.
Published: (2019-03-01)

Combined Therapy with Antihyperglycemic Oral Agents (Metformin, Sulfonylureas) and Insulin in the Management of Type 2 Diabetic Patients (Pathogenic Substantiation and Clinical Utility)
by: M.Yu. Horshunskaia
Published: (2015-05-01)

Reducing high risk of cardiovascular events in Type 2 diabetes mellitus: DIALOG Study results
by: I. E. Sapozhnikova, et al.
Published: (1970-01-01)

Investigation of socio-demographic, clinical and genetic factors associated with blood pressure and glycaemic control among indigenous South African adult patients
by: Masilela, Charity Mandisa
Published: (2021)

ANALYSIS OF THE PRACTICE OF COMBINATIONAL ANTIHYPERTENSION THERAPY BY THE DATA FROM TWO OUTPATIENT REGISTRIES
by: S. Yu. Martsevich, et al.
Published: (2017-10-01)

Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk
by: O. Yu. Korennova, et al.
Published: (2019-01-01)

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
by: E. I. Tarlovskaya, et al.
Published: (2015-09-01)

Combined antihypertensive treatment in hypertensive patients and type 2 diabetes mellitus
by: Yuriy Ivanovich Nestepov, et al.
Published: (2009-02-01)

Full-dose combinations of antihypertensive drugs: What has changed in experts' guidelines?
by: V V Fomin, et al.
Published: (2014-10-01)

EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
by: Steven G. Chrysant, et al.
Published: (2011-06-01)

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
by: Green J, et al.
Published: (2010-10-01)

Antihypertensive therapy in obese patients with arterial hypertension
by: О. M. Drapkina, et al.
Published: (2009-08-01)

MONO- OR COMBINED ANTIHYPERTENSIVE THERAPY IN WOMEN WITH ARTERIAL HYPERTENSION AND MODERATE RISK OF CARDIOVASCULAR DISEASES: WHAT’S BETTER?
by: R. I. Stryuk, et al.
Published: (2018-01-01)

QUALITY OF LIFE ANALYSIS IN DIABETES MELLITUS TYPE 2 PATIENTS USING MONOTHERAPY AND COMBINATION TREATMENT OF MEDICINE
by: Imaniar Noor Faridah, et al.
Published: (2017-04-01)

Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial
by: Kyeong Ho Yun, et al.
Published: (2021-01-01)

SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS
by: S. R. Gilyarevskiy
Published: (2015-09-01)

Diabetes Mellitus Type 2: How to Avoid Errors and to Increase the Effectiveness of Rreatment
by: V.I. Pankiv
Published: (2013-05-01)

The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
by: Juliya V Zhernakova, et al.
Published: (2019-09-01)

Antihypertensive combination therapy effects on cardiac remodelling in elderly patients
by: L. Kh. Gadzhieva, et al.
Published: (2013-10-01)